Interferons (IFNs) play pivotal roles in host innate immunity to protect against various virus infections. In respiratory virus infection, a major population of cells responsible for production of alpha IFN (IFN-␣) includes alveolar macrophages, conventional dendritic cells (cDCs), and plasmacytoid DCs (pDCs) (1). Of these cell types, pDCs are unique in their capacity to secrete large amounts of IFN-␣ (2). However, pDCs are not recruited unless viruses overcome the first defense line to cause systemic infection or can effectively prevent cDCs and alveolar macrophages from producing IFN-␣ (1). Since the signaling pathway leading to IFN-␣ production in pDCs is different from that in cDCs and alveolar macrophages, pDCs can combat even viruses that have acquired the ability to successfully limit IFN-␣ production of alveolar macrophages and cDCs during evolution. Whereas cDCs and alveolar macrophages employ the signaling pathway dependent on retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs), including RIG-I and melanoma differentiation-associated protein 5 (MDA5), pDCs utilize the Toll-like receptor 7 (TLR7)-and TLR9-dependent signaling pathway to produce IFN-␣. It was found that most paramyxoviruses, including parainfluenza viruses, have evolved the V protein that blocks the TLR7/9-dependent pathway as well as the RLR-dependent pathway to counteract such a highly organized IFN production system (3-12). Studies on the blocking mechanisms for the RLR-dependent pathway uncovered that the paramyxovirus V protein physically associated with MDA5 and prevented double-stranded RNA from binding to MDA5, thereby inhibiting MDA5-dependent signaling (13,14). In addition to this common mechanism targeting MDA5, some paramyxovirus V proteins have acquired an additional mechanism that targets a downstream step. The V protein of the human parainfluenza virus type 2 (HPIV2), mumps virus, and parainfluenza virus 5 in the genus Rubulavirus interacts with inducible I-kappa B (IB) kinase (IKKi)/TANK-binding kinase 1 (TBK1) and inhibits activation of interferon regulatory factor 3 (IRF3) by acting as alternative substrates for IKKi/TBK1 (15). On the other hand, the V proteins of Sendai virus (SeV), measles virus (MeV), and Newcastle disease virus interact with IRF3 and suppress the transcriptional activity of IRF3 (16). In contrast to these extensive studies on the blockade of RLR-dependent signaling, the molecular basis for the blockade of TLR7/9-dependent signaling has not been well characterized. This study was thus intended to elucidate how the paramyxovirus V proteins block TLR7/9-dependent signaling leading to IFN-␣.pDCs, unlike other cell types, express a definite amount of cytosolic latent IRF7 in addition to endosomal TLR7 and TLR9 (17,18). Engagement of TLR7 and TLR9 with guanosine-rich and uridine-rich single-stranded RNA and unmethylated DNA with CpG motifs, respectively, induces complex formation of IRF7 with myeloid differentiation factor 88 (MyD88), interleukin-1 (IL-1) receptor-associated kinase 4 (IRAK4), tum...